Lu J, Gullett JM, Kanneganti TD. Filoviruses: Innate Immunity, Inflammatory Cell Death, and Cytokines. Pathogens. 2022 Nov 23. 11 (12):[QxMD MEDLINE Link].
World Health Organization. Ebola virus disease – Democratic Republic of the Congo. WHO. Available at https://www.who.int/csr/don/19-september-2019-ebola-drc/en/. September 19, 2019; Accessed: September 20, 2019.
World Health Organization. Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of an Ebola outbreak in the Democratic Republic of the Congo: an example of integration of research into epidemic response. WHO. Available at https://www.who.int/csr/resources/publications/ebola/ebola-ring-vaccination-results-12-april-2019.pdf?ua=1. April 12, 2019; Accessed: April 17, 2019.
Mole B. As Ebola outbreak rages, vaccine is 97.5% effective, protecting over 90K people. ARS Technica. Available at https://arstechnica.com/science/2019/04/ebola-vaccine-is-97-5-effective-early-outbreak-data-suggests/. April 16, 2019; Accessed: April 17, 2019.
Patel PR, Shah SU. Ebola Virus. StatPearls. 2023 Jan. [QxMD MEDLINE Link]. [Full Text].
Mulangu S, Dodd LE, Davey RT Jr, and the, PALM Consortium Study Team. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. N Engl J Med. 2019 Dec 12. 381 (24):2293-2303. [QxMD MEDLINE Link]. [Full Text].
Hensley LE, Stevens EL, Yan SB, et al. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis. 2007 Nov 15. 196 Suppl 2:S390-9. [QxMD MEDLINE Link].
Geisbert TW, Hensley LE, Jahrling PB, et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet. 2003 Dec 13. 362(9400):1953-8. [QxMD MEDLINE Link].
Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A. 1996 Apr 16. 93(8):3602-7. [QxMD MEDLINE Link].
Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet. 2000 Jun 24. 355(9222):2210-5. [QxMD MEDLINE Link].
Roddy P, Howard N, Van Kerkhove MD, et al. Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One. 2012. 7(12):e52986. [QxMD MEDLINE Link]. [Full Text].
Amblard J, Obiang P, Edzang S, Prehaud C, Bouloy M, Guenno BL. Identification of the Ebola virus in Gabon in 1994. Lancet. 1997 Jan 18. 349(9046):181-2. [QxMD MEDLINE Link].
Swanepoel R, Leman PA, Burt FJ, et al. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis. 1996 Oct-Dec. 2(4):321-5. [QxMD MEDLINE Link].
Johnson E, Jaax N, White J, Jahrling P. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol. 1995 Aug. 76(4):227-36. [QxMD MEDLINE Link].
Allela L, Boury O, Pouillot R, et al. Ebola virus antibody prevalence in dogs and human risk. Emerg Infect Dis. 2005 Mar. 11(3):385-90. [QxMD MEDLINE Link].
Dokubo EK, Wendland A, Mate SE, et al. Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report. Lancet. Jul 2018.
Centers for Disease Control and Prevention. Review of Human-to-Human Transmission of Ebola Virus. Available at http://www.cdc.gov/vhf/ebola/transmission/human-transmission.html. Accessed: October 17, 2014.
World Health Organization. New Ebola outbreak declared in Democratic Republic of the Congo. World Health Organization. Available at https://www.who.int/news-room/detail/08-05-2018-new-ebola-outbreak-declared-in-democratic-republic-of-the-congo. May 8, 2018; Accessed: May 9, 2018.
Neuman S. Congo Declares New Ebola Outbreak After 2 Confirmed Cases. NPR. Available at https://www.npr.org/sections/thetwo-way/2018/05/09/609640513/congo-declares-new-ebola-outbreak-after-2-confirmed-cases. May 9, 2018; Accessed: May 9, 2018.
Centers for Disease Control and Prevention (CDC). 2014 Ebola Outbreak in West Africa. Centers for Disease Control and Prevention (CDC). Available at http://www.cdc.gov/vhf/ebola/outbreaks/guinea/. Accessed: September 4, 2014.
Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola Virus Disease in Guinea - Preliminary Report. N Engl J Med. 2014 Apr 16. [QxMD MEDLINE Link].
Wilson J. Peace Corps evacuates west Africa volunteers due to Ebola threat. CNN. Available at http://www.cnn.com/2014/07/30/health/ebola-american-aid-workers/index.html?hpt=hp_t1. Accessed: July 30, 2014.
Alsop Z. Ebola outbreak in Uganda "atypical", say experts. Lancet. 2007 Dec 22. 370(9605):2085. [QxMD MEDLINE Link].
Barrette RW, Metwally SA, Rowland JM, et al. Discovery of swine as a host for the Reston ebolavirus. Science. 2009 Jul 10. 325(5937):204-6. [QxMD MEDLINE Link].
Shoemaker T, Macneil A, Balinandi S, et al. Reemerging Sudan ebola virus disease in Uganda, 2011. Emerg Infect Dis. 2012 Sep. 18(9):1480-3. [QxMD MEDLINE Link]. [Full Text].
Bettini A, Lapa D, Garbuglia AR. Diagnostics of Ebola virus. Front Public Health. 2023. 11:1123024. [QxMD MEDLINE Link].
Abutaleb Y. U.S. FDA Issues Emergency Authorization for Two New Ebola Tests. Medscape. Oct 28 2014. [Full Text].
Geisbert TW, Jahrling PB. Differentiation of filoviruses by electron microscopy. Virus Res. 1995 Dec. 39(2-3):129-50. [QxMD MEDLINE Link].
FDA Accepts Merck’s Biologics License Application (BLA) and Grants Priority Review for V920, the Company’s Investigational Vaccine for Ebola Zaire Virus. Merck. 2019 Sep 17. Available at https://investors.merck.com/news/press-release-details/2019/FDA-Accepts-Mercks-Biologics-License-Application-BLA-and-Grants-Priority-Review-for-V920-the-Companys-Investigational-Vaccine-for-Ebola-Zaire-Virus/default.aspx.
Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet. 2017 Feb 4. 389 (10068):505-518. [QxMD MEDLINE Link]. [Full Text].
Ervebo (Ebola Zaire vaccine) [package insert]. Whitehouse Station, NJ: Merck. December 2019. Available at [Full Text].
Huggins J, Zhang ZX, Bray M. Antiviral drug therapy of filovirus infections: S-adenosylhom*ocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model. J Infect Dis. 1999 Feb. 179 Suppl 1:S240-7. [QxMD MEDLINE Link].
Smith LM, Hensley LE, Geisbert TW, et al. Interferon-ß Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever. J Infect Dis. 2013 Jan 15. [QxMD MEDLINE Link].
Baranovskiy AG, Babayeva ND, Suwa Y, Gu J, Pavlov YI, Tahirov TH. Structural basis for inhibition of DNA replication by aphidicolin. Nucleic Acids Res. 2014 Dec 16. 42 (22):14013-21. [QxMD MEDLINE Link]. [Full Text].
Kota KP, Benko JG, Mudhasani R, Retterer C, Tran JP, Bavari S, et al. High content image based analysis identifies cell cycle inhibitors as regulators of Ebola virus infection. Viruses. 2012 Sep 25. 4 (10):1865-77. [QxMD MEDLINE Link]. [Full Text].
Geisbert TW, Hensley LE, Kagan E, et al. Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. J Infect Dis. 2006 Jun 15. 193(12):1650-7. [QxMD MEDLINE Link].
Geisbert TW, Lee AC, Robbins M, et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet. 2010 May 29. 375(9729):1896-905. [QxMD MEDLINE Link].
Warren TK, Warfield KL, Wells J, et al. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med. 2010 Sep. 16(9):991-4. [QxMD MEDLINE Link].
Iversen PL, Warren TK, Wells JB, et al. Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections. Viruses. 2012 Nov 6. 4(11):2806-30. [QxMD MEDLINE Link]. [Full Text].
Heald AE, Iversen PL, Saoud JB, et al. Safety and pharmaco*kinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies. Antimicrob Agents Chemother. 2014 Nov. 58(11):6639-47. [QxMD MEDLINE Link]. [Full Text].
Qiu X, Audet J, Wong G, et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med. 2012 Jun 13. 4(138):138ra81. [QxMD MEDLINE Link].
Wilson JA, Hevey M, Bakken R, et al. Epitopes involved in antibody-mediated protection from Ebola virus. Science. 2000 Mar 3. 287(5458):1664-6. [QxMD MEDLINE Link].
Olinger GG Jr, Pettitt J, Kim D, et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci U S A. 2012 Oct 30. 109(44):18030-5. [QxMD MEDLINE Link]. [Full Text].
Pettitt J, Zeitlin L, Kim do H, et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody co*cktail. Sci Transl Med. 2013 Aug 21. 5(199):199ra113. [QxMD MEDLINE Link].
Qiu X, Wong G, Fernando L, et al. mAbs and Ad-vectored IFN-a therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms. Sci Transl Med. 2013 Oct 16. 5(207):207ra143. [QxMD MEDLINE Link].
Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014 Oct 2. 514(7520):47-53. [QxMD MEDLINE Link]. [Full Text].
Geisbert TW. Medical research: Ebola therapy protects severely ill monkeys. Nature. 2014 Oct 2. 514(7520):41-3. [QxMD MEDLINE Link].
Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med. 2014 Dec 18. 371(25):2402-9. [QxMD MEDLINE Link].
Zhang Y, Li D, Jin X, Huang Z. Fighting Ebola with ZMapp: spotlight on plant-made antibody. Sci China Life Sci. 2014 Oct. 57(10):987-8. [QxMD MEDLINE Link].
[Guideline] Centers for Disease Control and Prevention. Guidance on Personal Protective Equipment To Be Used by Healthcare Workers During Management of Patients with Ebola Virus Disease in U.S. Hospitals, Including Procedures for Putting On (Donning) and Removing (Doffing). Available at http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html. Accessed: October 21, 2014.
Brown T. CDC Panel Recommends Ebola Vaccine for Adults with Exposure Risk. Medscape Medical News. 2020 Feb 27. Available at https://www.medscape.com/viewarticle/925810.
Kennedy SB, Bolay F, Kieh M, et al. Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia. N Engl J Med. 2017 Oct 12. 377 (15):1438-1447. [QxMD MEDLINE Link].
Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ. Development of a preventive vaccine for Ebola virus infection in primates. Nature. 2000 Nov 30. 408(6812):605-9. [QxMD MEDLINE Link].
Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis. 2002 May. 8(5):503-7. [QxMD MEDLINE Link].
[Guideline] CDC. Evaluating Patients for Ebola: CDC Recommendations for Clinicians. Medscape Medical News. Oct 3 2014. [Full Text].
Centers for Disease Control and Prevention (CDC). Travel Health Notices. Centers for Disease Control and Prevention (CDC). Available at http://wwwnc.cdc.gov/travel/notices. Accessed: October 17, 2014.
